Hingez Therapeutics' Grant

Hingez Therapeutics raised a round of funding on September 18, 2018. Investors include National Institutes of Health.

Hingez Therapeutics is using molecular simulations to discover an orally deliverable small molecule to disrupt disease protein-protein interactions; this has the potential to be developed as a new dru…

Articles about Hingez Therapeutics' Grant: